Elanco Animal Health (ELAN) Intangibles (2017 - 2026)
Elanco Animal Health (ELAN) reported Intangibles of $3.2 billion for Q1 2026, down 11.25% on a YoY basis from $3.6 billion in Q1 2025, and down 5.37% sequentially from $3.4 billion in Q4 2025.
Elanco Animal Health (ELAN) Intangibles (2017 - 2026) Analysis & Trends
Elanco Animal Health (ELAN) has 10 years of Intangibles data on file, last reported at $3.2 billion in Q1 2026.
- For the quarter ending Q1 2026, Intangibles fell 11.25% year-over-year to $3.2 billion; the trailing twelve-month figure through Mar 2026 stood at $3.2 billion (down 11.25% YoY), and the FY2025 full-year result was $3.4 billion, down 7.42% from the prior year.
- Intangibles fell to $3.2 billion in Q1 2026, from $3.4 billion in the prior quarter.
- In the past five years, Intangibles ranged from a high of $5.4 billion in Q1 2022 to a low of $3.2 billion in Q1 2026.
- A 5-year average of $4.2 billion and a median of $4.2 billion in 2024 frame the typical range for Intangibles.
- Across the five-year window, Intangibles decreased 6.11% in 2023 and dropped 18.09% in 2024, its largest moves.
- Tracing ELAN's Intangibles over 5 years: stood at $4.8 billion in 2022, then decreased by 7.19% to $4.5 billion in 2023, then dropped by 18.09% to $3.7 billion in 2024, then slipped by 7.42% to $3.4 billion in 2025, then decreased by 5.37% to $3.2 billion in 2026.
- Business Quant data shows ELAN's Intangibles at $3.2 billion in Q1 2026, $3.4 billion in Q4 2025, and $3.6 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 34.07 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.61 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 959.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 21.80 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 473.93 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.48 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.23 Bn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 78.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.23 Bn |
| Dec 31, 2025 | 3.41 Bn |
| Sep 30, 2025 | 3.60 Bn |
| Jun 30, 2025 | 3.71 Bn |
| Mar 31, 2025 | 3.63 Bn |
| Dec 31, 2024 | 3.68 Bn |
| Sep 30, 2024 | 4.01 Bn |
| Jun 30, 2024 | 4.00 Bn |
| Mar 31, 2024 | 4.20 Bn |
| Dec 31, 2023 | 4.49 Bn |
| Sep 30, 2023 | 4.48 Bn |
| Jun 30, 2023 | 4.68 Bn |
| Mar 31, 2023 | 4.79 Bn |
| Dec 31, 2022 | 4.84 Bn |
| Sep 30, 2022 | 4.77 Bn |
| Jun 30, 2022 | 5.06 Bn |
| Mar 31, 2022 | 5.40 Bn |
| Dec 31, 2021 | 5.59 Bn |
| Sep 30, 2021 | 5.82 Bn |
| Jun 30, 2021 | 5.76 Bn |